Plasma levels of bradykinin are suppressed in factor XII-deficient mice

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH06-03-0128
Issue:2006: 95/6 (June) pp. 917-1051
Pages:1003-1010

Plasma levels of bradykinin are suppressed in factor XII-deficient mice

Takayuki Iwaki, Francis J. Castellino
W. M. Keck Center for Transgene Research and the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA

Summary

A genetically-transmissible factor (F) XII-inactivated allele has been produced in mice by targeted replacement of exons 3–8 of the FXII gene with the neomycin resistance gene. Interbreeding of these mice provided offspring homozygous for two inactivated FXII alleles (FXII-/-). Male and female FXII-deficient mice bred normally in all genotypic combinations of the heterozygous and homozygous states,and the offspring survived to adulthood, suggesting that a total FXII deficiency does not affect embryonic development and survival. Neither FXII transcripts nor FXII antigen was found in various tissues of adult FXII -/- mice. No obvious unchallenged coagulopathies were present in FXII-/- adult mice, despite greatly prolonged activated partial thromboplastin times in this mouse cohort.FXII-/- mice were then used to assess the in vivo importance of the plasma FXII/prekallikrein/kininogen pathway in provision of resting plasma bradykinin (BK) levels and in generation of plasma BK stimulated by contact with an artificial surface, using a new and greatly improved plasma BK assay developed during these studies. It was found that approximately 50% of resting BK, and all of the contact-stimulated plasma BK, was provided by this FXII-dependent pathway, without a requirement for FXI.These results provide clear evidence that surface-stimulated BK production, in mice, is dependent on the activation of FXII.

Keywords

FXII deficiency, targeted gene replacement, bradykinin generation, vasoactivity, reproduction, intrinsic coagulation pathway, contact activation

DOI

http://dx.doi.org/10.1160/TH06-03-0128

You may also be interested in...

1.

A. Hahn (1), S. Reitemeier (1), J. Gottschalk (1), M. Haense (2), V. Schmidt (2), K. Steinbach-Sobiraj (2), M.-E. Krautwald-Junghanns (2), A. Einspanier (1)

Tierärztliche Praxis Kleintiere 2011 39 4: 249-257

2.

S. Spankowsky (1), S. Arlt (1), G. Arndt (2), W. Heuwieser (1)

Tierärztliche Praxis Großtiere 2011 39 3: 135-142

3.

K. Iijima (1), Y. Arakawa (1), Y. Sugahara (1), M. Matsushita (1), Y. Moriguchi (1), H. Shimohiro (1), M. Nakagawa (1)

Thrombosis and Haemostasis 2011 105 3: 473-478

http://dx.doi.org/10.1160/TH10-02-0123



Articles

You've 473 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...